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Abstract 
Review on AKAP12, with data on DNA/RNA, on 
the protein encoded and where the gene is 
implicated. 
Identity 
Other names: Gravin, SSeCKS, AKAP250, Srcs5, 
Tsga12 
HGNC (Hugo): AKAP12 
Location: 6q25.1 
Location (base pair) 
Starts at 151561134 and ends at 151679694 bp from 
pter (according to hg19-Feb_2009) 
DNA/RNA 
The AKAP12 gene and promoter structure is 
strongly conserved from fish to humans, including 
syntenic regions conserved in the mouse (chrom. 10) 
and rat (chrom. 1). No family members 
(homologues) other than AKAP12 exist within a 
given species. 
AKAP12 (6q24-25.2) in normal cells probed with a about 5Kb human AKAP12 probe. Courtesy of Irwin Gelman; adapted from 
Xia et al., Cancer Res.61:5644-5651, 2001. 
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Human and mouse cells have similar exon/intron usage and spacing. AKAP12 has three independent promoters, α, β, and γ. 
The gamma promoter is active only in the testes while the α and β are co-active in most cells and tissues studied. Exons 1A1 
and 1A2 combine to then splice to a common splice acceptor on Exon 2 used by Exon 1B. Exons 1A1 and 1A2 produce the N-
terminal 103 amino acids of "AKAP12 alpha" whereas Exon 1B encodes the N-terminal 8 amino acids of "AKAP12 β"; the 
remaining amino acids are encoded in Exon 2. "AKAP12 gamma" is encoded by a read-through transcript starting in the intron 
upstream of Exon 2, utilizing an in-frame ATG in Exon 2. Therefore, the α, β, and γ transcripts encode proteins that only differ in 
their N-termini. 
Transcription 
Human and rodent AKAP12 is expressed 
ubiquitously, with greater expression in 
mesenchymal cells, expression in specific epithelial 
types, such as breast and prostate, and little in most 
endothelial cells. Several highly specialized, 
differentiated cells type, such as parietal cells in the 
glomerulus, pericytes, astrocytes and Purkinje cells, 
show especially strong expression. 
Pseudogene 
None. 
Protein 
Expression 
AKAP12 isoforms are expressed in most tissue and 
organ types, with high expression levels in the testes, 
ovary, brain, lung and heart. Most mesenchyme, 
smooth muscle and some epithelial cells (breast, 
prostate, lung, ovary) express significant AKAP12 
levels. Lower levels of AKAP12 are found in 
endothelial cells, although express in these cells is 
usually associated with wounding and/or 
inflammation. High expression is also found in some 
specialized, differentiated cells such as the parietal 
cells of the glomerulus, pericytes, astrocytes and 
Purkinje cells. 
Localisation 
Most cell types display a cortical cytoskeletal 
staining pattern for AKAP12, with enrichment at the 
plasma membrane (associated with N-terminal 
myristylation and at least three N-terminal polybasic 
domains) and in the perinucleus. However, some 
staining has been observed in cell nuclei, probably 
directed by 4 SV40 Tag-like nuclear localization 
signals (NLS) found in the N-terminal third of the 
protein. 
Function 
1) Facilitates the sensitization/resensitization
reaction of beta-adrenergic receptors.
2) Scaffolds protein kinase (PK) A, PKC, and SRC.
3) Autoantigen in some cases of myasthenia gravis.
4) Anti-angiogenic factor. The rodent orthologue has
been shown to inhibit brain angiogenesis and induce
the blood-brain barrier, and to inhibit VEGF-
mediated metastasis.
5) Metastasis suppressor (see Gelman, 2012). Many
studies show i) AKAP12 downregulation in
metastases compared to primary-site tumors,
associated with hypermethylation of promoter CpG
islands, ii) AKAP12-/- mice are tumor- and
metastasis-prone to skin carcinogens, iii) increased
spontaneous lymph node metastasis of high-grade
prostatic intraepithelial neoplasia in transgenic
models, and iv) selective suppression of spontaneous
and experimental metastasis following re-expression
of rodent Akap12 in MAT-LyLu prostate cancer
cells.
6) Effector of Polo-like kinase 1 to regulate
cytokinesis.
7) Maintenance of barrier functions such as blood-
brain, blood-retinal barriers and fibrotic scars in
CNS repair.
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A: Except for testes, most cells express four major isoforms of AKAP12 protein. The 305 kDa isoforms is the myristylated 
AKAP12alpha whereas the 287 kDa isoforms is AKAP12beta. The 250 kDa and 43 kDa isoforms are proteolytic cleavage 
products common to the AKAP12alpha and beta isoforms. B: Human AKAP12alpha encodes a 1,780 amino acids full-length 
protein. The first about 1,000 amino acids of human and rodent AKAP12 share 83% identity followed by about 600 amino acids 
with less than 20% identity. The N-terminal homology domain (green) shows about 40% identity to the Xgl (Xenopus gravin-like) 
gene in Xenopus. Both human and rodent AKAP12 share a shorter C-terminal domain containing the PKA-RII binding (AKAP) 
domain (green box in human AKAP12). 
8) Regulation of adhesion, chemotaxis and
invasiveness through the control of actin cytoskeletal
remodeling.
Homology 
Southern blotting analysis as well as analysis of 
sequenced genomes indicates that vertebrates 
encode single AKAP12 orthologues, with no gene 
family members.  
Thus, the protein diversity of this gene stems from 
promoter choice, alternative splicing, proteolytic 
maturation and post-translational modification. 
AKAP12 has limited sequence homology based on 
short domains.  
For example, the C-terminal AKAP domain is 
homologous to the analogous domain in AKP79. 
Also, AKAP12 shares some so-called MARCKS 
protein-like effector domains- positively charged 
stretches of amino acids involved in plasma 
membrane targeting. 
Mutations 
141 mutations (mostly point mutants and some small 
deletions) have been described in COSMIC, the vast 
majority of which are found in the major protein-
coding exon ("exon 2") 
ESR1-AKAP12 fusions have been recently 
described (Ma et al., 2014) in clinical cases of breast 
cancer. . 
There are at least 539 single nucleotide 
polymorphisms (SNP). 59 study datasets for 
AKAP12 SNPs described 
in GWAS analyses 
For example, HGVST779 identifies AKAP12 SNPs 
associated with chronic myelogenous leukemia. 
 Another study identifies AKAP12 SNPs associated 
with psychiatric depression (Ripke et al., 2012).  
 A number of QTLs have been described associated 
with susceptibility for prostate cancer and insulin 
sensitivity, and for HDL cholesterol. 
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AKAP12 is phosphorylated by PLK1 on T766 during metaphase, and shRNa knockdown of AKAP12 leads to cytokinesis failure 
(Canton et al., 2012). 
Implicated in 
Prostate cancer 
Note 
Tumor/metastasis suppressor. 
Prognosis 
AKAP12 downregulation correlates with earlier 
time-to-onset of metastasis (Ko et al., 2014). 
Cytogenetics 
gene deletion at 6q24-25.1. 
Oncogenesis 
Presumably, the loss of AKAP12's scaffolding 
activity for kinases such as Src and PKC result in 
hyperactivated pathways that contribute to 
oncogenic transformation, as shown in Su et al., 
2010, and Su et al., 2013. 
Melanoma 
Note 
Tumor/metastasis suppressor/promoter. 
Prognosis 
Some papers identify AKAP12 downregulation as a 
marker human melanoma progression (Hacker et al., 
2008; Bonazzi et al., 2009), or that its genetic loss in 
transgenic models leads to a metastasis-prone 
condition induced by skin carcinogens (Akakura et 
al., 2011).   
However, one paper suggests that hypoxia-induced 
expression of AKAP12-variant 2 (β isoform) 
enhances melanoma migration and invasiveness. 
Oncogenesis 
Presumably, the loss of AKAP12's scaffolding 
activity for kinases such as Src and PKC result in 
hyperactivated pathways that contribute to 
oncogenic transformation, as shown in Su et al., 
2010 and Su et al., 2013. 
Ovarian cancer 
Note 
Possible mediator of drug-resistance. 
Prognosis 
AKAP12 upregulation associated with resistance to 
platins and taxanes (Chappell et al., 2012; Bateman 
et al., 2015). 
Oncogenesis 
Presumably, the upregulation of AKAP12, and its 
ability to scaffold kinases such as Src and PKC, and 
to move them to cellular specific compartments, 
leads to pathways that facilitate drug resistance, as 
described in Le and Bast 2011. 
Pancreatic cancer 
Note 
Possible tumor/metastasis suppressor. 
Prognosis 
Whereas AKAP12 upregulation was noted in human 
pancreatic cells lines compared to immortalized 
human pancreatic ductal epithelial cells (Cao et al., 
Cancer Biol Ther. 2004, 3(11):1081-9), AKAP12 
loss (due to promoter hypermethylation) correlated 
with increased liver metastasis in pancreatic ductal 
adenocarcinoma (Mardin et al., 2010). 
Oncogenesis 
Presumably, the loss of AKAP12's scaffolding 
activity for kinases such as Src and PKC result in 
hyperactivated pathways that contribute to 
oncogenic transformation, as shown in Su et al. 
2010, and Su et al. 2013. 
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Left- Oncomine analysis (http://www.oncomine.org) of Lapointe prostate cancer expression data (Proc Natl Acad Sci U S A 
2004;101:811-6) showing AKAP12 downregulation in human prostate cancer metastasis compared with levels in primary 
prostate cancer (1 prostate cancer) or normal prostate tissue. F, Kaplan-Meier plot analysis (http://www.cbioportal.org/public-
portal/) of metastasis occurrence vs. time to onset in 37 prostate cancer metastasis cases from Taylor et al., 2010 in which 11 
cases (29.7%) displayed AKAP12 downregulation compared with levels in primary prostate cancer lesions versus 26 cases with 
no change in AKAP12 levels. 
A majority of high-grade (HG) serous ovarian cancer (SOC) patients develop resistant disease despite high initial response rates 
to platinum/paclitaxel-based chemotherapy. We identified shed/secreted proteins in preclinical models of paclitaxel-resistant 
human HGSOC models and correlated these candidate proteins with patient outcomes using public data from HGSOC patients. 
Proteomic analyses of a HGSOC cell line secretome was compared to those from a syngeneic paclitaxel-resistant variant and 
from a line established from an intrinsically chemorefractory HGSOC patient. Associations between the identified candidate 
proteins and patient outcome were assessed in a discovery cohort of 545 patients and two validation cohorts totaling 795 
independent SOC patients. Among the 81 differentially abundant proteins identified (q < 0.05) from paclitaxel-sensitive vs -
resistant HGSOC cell secretomes, AKAP12 was verified to be elevated in all models of paclitaxel-resistant HGSOC. 
Furthermore, elevated AKAP12 transcript expression was associated with worse progression-free and overall survival. 
Associations with outcome were observed in three independent cohorts and remained significant after adjusted multivariate 
modeling. We further provide evidence to support that differential gene methylation status is associated with elevated expression 
of AKAP12 in taxol-resistant ovarian cancer cells and ovarian cancer patient subsets. Elevated expression and 
shedding/secretion of AKAP12 is characteristic of paclitaxel-resistant HGSOC cells, and elevated AKAP12 transcript expression 
is a poor prognostic and predictive marker for progression-free and overall survival in SOC patients. [from Bateman et al., 2015]. 
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Colon cancer 
Note 
Possible tumor/metastasis suppressor. 
Prognosis 
Downregulation of AKAP12 correlated with colon 
cancer progression (Zhu et al., J Cancer Res Ther. 
2013, 9(3):467-70), especially due to promoter 
hypermethylation (Mori et al., 2006; Liu et al., 
2010).   
Moreover, AKAP12 expression is positively 
regulated by TGFβ; in a SMAD4 -dependent manner 
in colon cancer cell lines (Ali et al., 2010), and given 
that SMAD4 is often mutated or deleted in colon 
cancer (Bellam and Pasche, 2010), the 
downregulation of AKAP12 might be related to 
SMAD4 loss.   
Re-expression of AKAP12 inhibits the metastatic 
potential of colorectal carcinoma cells (Liu et al., 
2011). 
Lung cancer 
Note 
Possible tumor suppressor. 
Prognosis 
ownregulation of AKAP12 due to promoter 
hypermethylation in lung cancer as a susceptibility 
(Tessema et al., 2008) or progression marker (Jo et 
al., 2010).   
As in the case of ovarian cancer, AKAP12 
expression increases in cisplatin-resistant variants of 
lung cancer cell lines (Lopez-Ayllon et al., 2014. 
Oncogenesis 
Presumably, the loss of AKAP12's scaffolding 
activity for kinases such as Src and PKC result in 
hyperactivated pathways that contribute to 
oncogenic transformation, as shown in Su et al., 
2010 and Su et al., 2013. 
Gastric cancer 
Note 
Possible tumor suppressor. 
Prognosis 
Downregulation of AKAP12 due to promoter 
hypermethylation in gastric cancer (Choi et al., 
2004) or in Barrett's esophagus (Jin et al., 2008). 
Oncogenesis 
Presumably, the loss of AKAP12's scaffolding 
activity for kinases such as Src and PKC result in 
hyperactivated pathways that contribute to 
oncogenic transformation, as shown in Su et al., 
2010 and Su et al., 2013. 
Liver cancer 
Note 
Possible tumor suppressor. 
Prognosis 
Downregulation of AKAP12 due to promoter 
hypermethylation in liver cancer (Goeppert et al., 
2010; Hayashi et al., 2012). 
Oncogenesis 
Presumably, the loss of AKAP12's scaffolding 
activity for kinases such as Src and PKC result in 
hyperactivated pathways that contribute to 
oncogenic transformation, as shown in Su et al., 
2010 and Su et al., 2013. 
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